Omada Health, Inc. OMDA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 309.76M | 283.30M | 260.21M | 232.34M | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 309.76M | 283.30M | 260.21M | 232.34M | -- |
| Cost of Revenue | 98.55M | 95.56M | 89.27M | 82.93M | -- |
| Gross Profit | 211.21M | 187.73M | 170.94M | 149.41M | -- |
| SG&A Expenses | 162.50M | 151.52M | 142.23M | 133.44M | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 310.22M | 291.65M | 272.18M | 254.70M | -- |
| Operating Income | -464.00K | -8.36M | -11.97M | -22.35M | -- |
| Income Before Tax | 4.31M | -6.30M | -12.78M | -26.19M | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 4.31 | -6.30 | -12.78 | -26.19 | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 4.31M | -6.30M | -12.78M | -26.19M | -- |
| EBIT | -464.00K | -8.36M | -11.97M | -22.35M | -- |
| EBITDA | 5.43M | -2.69M | -6.48M | -17.03M | -- |
| EPS Basic | 0.07 | -0.26 | -1.35 | -2.48 | -- |
| Normalized Basic EPS | 0.07 | -0.14 | -0.82 | -1.53 | -- |
| EPS Diluted | 0.06 | -0.27 | -1.36 | -2.48 | -- |
| Normalized Diluted EPS | 0.06 | -0.14 | -0.83 | -1.53 | -- |
| Average Basic Shares Outstanding | 234.32M | 196.61M | 145.93M | 95.82M | -- |
| Average Diluted Shares Outstanding | 244.46M | 202.48M | 151.80M | 95.82M | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |